251 posters,  10 sessions,  768 authors,  134 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

Poster 122
REAL-WORLD EXPERIENCE WITH "MICROHEMATURIA" IN POSTMENOPAUSAL WOMEN

Primary tabs

Rate

No votes yet

Statistics

443 reads

Real-World Evaluation of “Microhematuria” in Postmenopausal Women

Background:

•In 2012, the American Urological Association (AUA) revised the asymptomatic microscopic hematuria (AMH) guidelines to maximize detection rates of urinary tract malignancies, but unfortunately the guidelines do not explicitly address gender-specific recommendations.1
•The guidelines recommend:
1.A thorough evaluation of any patient with three or greater red blood cells per high powered field (≥3RBC/HPF) on one properly collected urinary specimen in the absence of an obvious benign cause.1
2.Cystoscopy for all patients over 35 years old
3.Upper tract imaging using multi-phasic computed tomography (CT) urography.
•Bladder cancer is 3-4 times less common in females as compared to the equivalent male population
•Prevalence of microhematuria is as high as 20.1% in postmenopausal women2
•The objective of this study was to describe adherence to AUA AMH guidelines by urology and urogynecology providers in a population of postmenopausal women at a tertiary care center.
•Additionally, we sought to assess the prevalence of urinary tract malignancy in our population of postmenopausal women.
 
 
Enter Poster ID (e.gGoNextPreviousCurrent